April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.9 USD | +0.76% | -2.37% | -14.25% |
May. 30 | JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261 | MT |
May. 23 | Some of the biggest splits in Corporate America | RE |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
194.9 USD | +0.76% | -2.37% | 16.43B | ||
142 USD | +1.89% | +0.49% | 15.77B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.25% | 16.43B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
+0.49% | 25.03B | |
+4.31% | 17.88B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B | |
+24.51% | 12.7B |
- Stock Market
- Equities
- LH Stock
- News Labcorp Holdings Inc.
- US FDA publishes final rule for laboratory developed tests